Total Funding
20
Total FundingSeed raised
Growth Score
pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
206926
DMD Therapeutics intends to use the funds to move DMD-813 into drug development for the treatment of Duchenne Muscular Dystrophy.
Ron Berenson: President and CEO
About the Company
DMD Therapeutics Inc. operates as a biotechnology company. The company was incorporated in 2015 and is based in Seattle, Washington.
